Last reviewed · How we verify

ENERGI-F703 GEL — Competitive Intelligence Brief

ENERGI-F703 GEL (ENERGI-F703 GEL) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Dermatology / Wound Care.

phase 3 Dermatology / Wound Care Small molecule Live · refreshed every 30 min

Target snapshot

ENERGI-F703 GEL (ENERGI-F703 GEL) — Energenesis Biomedical Co., Ltd.. ENERGI-F703 is a topical gel formulation designed to promote wound healing and tissue regeneration through growth factor delivery.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ENERGI-F703 GEL TARGET ENERGI-F703 GEL Energenesis Biomedical Co., Ltd. phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ENERGI-F703 GEL — Competitive Intelligence Brief. https://druglandscape.com/ci/energi-f703-gel. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: